Scuttled by a bad IV bag? A small biotech is slapped with a hold following three SAEs
Shares of DiaMedica $DMAC are being savaged Thursday morning after the biotech put out word that the FDA has slapped a clinical hold on its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
